After nearly a decade of sky-high prices, generics have sent the price of the HIV prevention drug PrEP plummeting. What kept it so expensive for so long, and will the price drop help us finally eradicate HIV?

Guests:

Robin Feldman, Professor of Law, UC Hastings; Director of the Center for Innovation

Tahir Amin, Co-Executive Director, I-MAK

Oni Blackstock, MD, Primary care and HIV physician

Tim Horn, Director of Health Care Access, National Alliance of State and Territorial AIDS Directors

Craig Garthwaite, Director of Health Care, Kellogg School of Management, Northwestern Univ.

Dig deeper into the research and tradeoffs of prescription drug pricing on our website: https://tradeoffs.org/2021/04/22/preventing-hiv-just-got-a-lot-cheaper-what-took-so-long/

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter

Support this type of journalism today, with a gift: https://tradeoffs.org/donate

Follow us on Twitter: https://twitter.com/tradeoffspod

Hosted on Acast. See acast.com/privacy for more information.

Preventing HIV Just Got A Lot Cheaper. What Took So Long?